Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Angela R Wateska"'
Autor:
Leila A Haidari, Diana L Connor, Angela R Wateska, Shawn T Brown, Leslie E Mueller, Bryan A Norman, Michelle M Schmitz, Proma Paul, Jayant Rajgopal, Joel S Welling, Jim Leonard, Sheng-I Chen, Bruce Y Lee
Publikováno v:
PLoS ONE, Vol 8, Iss 5, p e64303 (2013)
When addressing the urgent task of improving vaccine supply chains, especially to accommodate the introduction of new vaccines, there is often a heavy emphasis on stationary storage. Currently, donations to vaccine supply chains occur largely in the
Externí odkaz:
https://doaj.org/article/bfe1654e29e24f2a869134c698594c62
Autor:
Bruce Y Lee, Tina-Marie Assi, Korngamon Rookkapan, Angela R Wateska, Jayant Rajgopal, Vorasith Sornsrivichai, Sheng-I Chen, Shawn T Brown, Joel Welling, Bryan A Norman, Diana L Connor, Rachel R Bailey, Anirban Jana, Willem G Van Panhuis, Donald S Burke
Publikováno v:
PLoS ONE, Vol 6, Iss 9, p e24673 (2011)
Although the substantial burdens of rotavirus and pneumococcal disease have motivated many countries to consider introducing the rotavirus vaccine (RV) and heptavalent pneumococcal conjugate vaccine (PCV-7) to their National Immunization Programs (EP
Externí odkaz:
https://doaj.org/article/3de61e7ff8234cf2a845bcdfc7b80e0b
Autor:
Angela R. Wateska, Mary Patricia Nowalk, Chyongchiou J. Lin, Lee H. Harrison, William Schaffner, Richard K. Zimmerman, Kenneth J. Smith
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 4, Pp 863-872 (2019)
In the U.S., pneumococcal polysaccharide vaccine (PPSV23) uptake among high-risk adults aged
Externí odkaz:
https://doaj.org/article/ed68a4d7ca044ee7b070f16641942c28
Autor:
Richard K. Zimmerman, Chyongchiou J. Lin, Lee H. Harrison, Mary Patricia Nowalk, William Schaffner, Kenneth J. Smith, Angela R. Wateska
Publikováno v:
Am J Prev Med
Introduction Use of the 13-valent pneumococcal conjugate vaccine in nonimmunocompromised adults aged ≥65 years is controversial. Higher-valency conjugate vaccines (15-valent and 20-valent ) are under development; their potential cost effectiveness
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d79e4d0033c60745080ed3fb9b1c9f3b
https://doi.org/10.1016/j.amepre.2021.01.023
https://doi.org/10.1016/j.amepre.2021.01.023
Autor:
Kenneth J. Smith, Angela R. Wateska, Mary Patricia Nowalk, Chyongchiou J. Lin, Lee H. Harrison, William Schaffner, Richard K. Zimmerman
Publikováno v:
Infectious Diseases and Therapy.
US pneumococcal vaccination recommendations for adults aged 65 years or older recently changed, with options for either 20-valent pneumococcal conjugate vaccine (PCV20) or the combination of 15-valent conjugate vaccine (PCV15) followed by 23-valent p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bfffea9a25d647fc297a6770397179c
https://doi.org/10.1007/s40121-022-00669-x
https://doi.org/10.1007/s40121-022-00669-x
Autor:
Angela R. Wateska, Mary Patricia Nowalk, Chyongchiou J. Lin, Lee H. Harrison, William Schaffner, Richard K. Zimmerman, Kenneth J. Smith
Publikováno v:
Vaccine. 40(50)
The 15- and 20-valent pneumococcal conjugate vaccines (PCV15/PCV20) were recently recommended for US adults, giving either PCV20 alone or PCV15 followed by 23-valent pneumococcal polysaccharide vaccine (PPSV23) to all 65 + -year-olds and to high-risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13dcc47136e750e55b76e42b1eaf9d2f
https://pubmed.ncbi.nlm.nih.gov/36336526
https://pubmed.ncbi.nlm.nih.gov/36336526
Autor:
Richard K. Zimmerman, Lee H. Harrison, Chyongchiou J. Lin, William Schaffner, Mary Patricia Nowalk, Angela R. Wateska, Kenneth J. Smith
Publikováno v:
J Am Geriatr Soc
Background/objectives Recently revised vaccination recommendations for US adults, aged 65 years and older, include both 23-valent pneumococcal polysaccharide vaccine (PPSV23) and 13-valent pneumococcal conjugate vaccine (PCV13), with PCV13 now recomm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1acfffcb73d0544170c3e834f7e0092
https://doi.org/10.1111/jgs.16373
https://doi.org/10.1111/jgs.16373
Autor:
Kenneth J. Smith, Lee H. Harrison, Angela R. Wateska, Mary Patricia Nowalk, Chyongchiou J. Lin, William Schaffner, Richard K. Zimmerman
Publikováno v:
Vaccine
Background The COVID-19 pandemic is causing declines in childhood immunization rates. We examined potential COVID-19-related changes in pediatric 13-valent pneumococcal conjugate vaccine (PCV13) use, subsequent impact on childhood and adult pneumococ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8ddd612fdead5306b3a3f5a15f93f56
http://europepmc.org/articles/PMC8215512
http://europepmc.org/articles/PMC8215512
Autor:
Lee H. Harrison, Chyongchiou J. Lin, William Schaffner, Kenneth J. Smith, Angela R. Wateska, Richard K. Zimmerman, Mary Patricia Nowalk
Publikováno v:
J Community Health
INTRODUCTION: In US adults aged
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86fc46cfc00b49e12bf6ef9a2fafa48d
https://doi.org/10.1007/s10900-019-00716-8
https://doi.org/10.1007/s10900-019-00716-8
Autor:
Richard K. Zimmerman, Kenneth J. Smith, Angela R. Wateska, Lee H. Harrison, William Schaffner, Chyongchiou J. Lin, Mary Patricia Nowalk
Publikováno v:
Human Vaccines & Immunotherapeutics. 15:863-872
In the U.S., pneumococcal polysaccharide vaccine (PPSV23) uptake among high-risk adults aged
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e58f167aa756ff6417ed4def2d8c9f60
https://doi.org/10.1080/21645515.2018.1564439
https://doi.org/10.1080/21645515.2018.1564439